Recent Posts
- HealthInvest June 2026: A Look Inside Australia’s Healthcare Innovations
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences
- Lifesaving Capital: How impact investing is shaping the future of biotech
- Investor Relations: the quiet advantage powering ASX microcaps
- HealthInvest Sydney: Life Sciences in the Investor Spotlight
Archives
Novogen's Dr James Garner explores the company's transformation
March 10th, 2017
by
IR Department team
Read More
- 1
